Search Results 61-70 of 18672 for Hepatitis C
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
During her three-day checkup, she was told that X-rays had found a cancerous tumor on her liver. So, instead of talking about her Hepatitis C treatments, she ...
For hepatitis C virus infection: Adults—One tablet once a day, taken for 12 weeks. Each tablet contains sofosbuvir 400 milligrams (mg) and velpatasvir 100 ...
Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even death. On the next Mayo Clinic Radio, infectious diseases specialist Dr. Stacey ...
Glecaprevir and pibrentasvir combination is used to treat chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis ...
People with chronic liver disease, including hepatitis B or hepatitis C; Anyone wishing to obtain protection (immunity). If you're concerned about your risk ...
Peginterferon alfa-2a injection is used alone or together with other medicines (eg, ribavirin)to treat chronic hepatitis C infection in patients who are not ...
Medicines to control hepatitis. Medicines may limit further damage to liver cells caused by hepatitis B or C through specific treatment of these viruses.
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and ...
To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.